Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fufang Yinhua Lishi Granules (复方银花利湿颗粒) is a traditional Chinese medicine compound formulation used primarily for the treatment of symptoms associated with upper respiratory tract infections, such as those seen in common cold and influenza. The formula typically contains multiple herbal ingredients, including honeysuckle (金银花), which is known for its heat-clearing and detoxifying properties. The preparation aims to clear heat, resolve dampness, relieve exterior syndromes (such as fever and chills), and detoxify the body. It is commonly used in China for symptomatic relief of fever, sore throat, cough, nasal congestion, headache, muscle aches—especially when these are attributed to "wind-heat" or "damp-heat" patterns according to traditional Chinese medicine theory[3]. Its mechanism of action involves anti-inflammatory effects and possible antiviral activity due to its herbal components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fufang yinhua lishi granules.